Oculis Holding AG (OCS) Net Cash Flow (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Net Cash Flow of $10.6 million in Q1 2026, down 87.5% quarter-over-quarter from $84.5 million in Q4 2025, and down 88.82% on a YoY basis from $94.4 million in Q1 2025.

Oculis Holding AG (OCS) Net Cash Flow (2022 - 2026) Analysis & Trends

Oculis Holding AG's Net Cash Flow history runs 5 years deep, the most recent figure standing at $10.6 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 88.82% year-over-year to $10.6 million; the TTM figure through Mar 2026 stood at $56.0 million (down 40.7% YoY), while the FY2025 annual figure was $74.7 million, up 693.26% from the prior year.
  • Net Cash Flow was $10.6 million for Q1 2026 at Oculis Holding AG, down from $84.5 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $94.4 million in Q1 2025 to a low of -$20.1 million in Q2 2025.
  • Historically, Net Cash Flow has averaged $14.7 million across 5 years, with a median of -$5.7 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Net Cash Flow plunged 205.76% in 2023, then surged 1030.89% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$8.6 million in 2022, then soared by 219.38% to $10.3 million in 2023, then slumped by 187.95% to -$9.1 million in 2024, then jumped by 1030.89% to $84.5 million in 2025, then tumbled by 87.5% to $10.6 million in 2026.
  • The last three Net Cash Flow figures came in at $10.6 million (Q1 2026), $84.5 million (Q4 2025), and -$18.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 2.44 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 625.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -2.44 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 457.40 Mn
9 Abivax 90.15 Bn 90.15 Bn - 664,983.53
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 10.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.56 Mn
Mar 31, 2026 10.56 Mn
Dec 31, 2025 84.47 Mn
Dec 31, 2025 84.47 Mn
Sep 30, 2025 -18.91 Mn
Sep 30, 2025 -18.91 Mn
Jun 30, 2025 -20.10 Mn
Jun 30, 2025 -20.10 Mn
Mar 31, 2025 94.39 Mn
Mar 31, 2025 94.39 Mn
Dec 31, 2024 -9.07 Mn
Dec 31, 2024 -9.07 Mn
Sep 30, 2024 -13.33 Mn
Sep 30, 2024 -13.33 Mn
Jun 30, 2024 22.47 Mn
Jun 30, 2024 22.47 Mn
Mar 31, 2024 -17.87 Mn
Mar 31, 2024 -17.87 Mn
Dec 31, 2023 10.32 Mn
Dec 31, 2023 10.32 Mn